Literature DB >> 33956177

Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome: evaluation by computed tomography perfusion imaging.

Xiang Guo1, Xuexia Yuan1, Lingyun Gao1, Yueqin Chen1, Hao Yu1, Weijian Chen2, Yunjun Yang2, Zhen Chong1, Zhanguo Sun1, Feng Jin3, Deguo Liu4.   

Abstract

OBJECTIVE: To explore the value of computed tomography perfusion (CTP) imaging for evaluating the efficacy of encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome (MMS).
METHODS: Forty-three patients with MMS (48 hemispheres) who received EDAS treatment were examined using CTP and DSA before and after surgery. CTP of the ipsilateral cortex, contralateral mirror area, and pons region were measured, and the relative cerebral blood flow (rCBF) and volume (rCBV), mean transit time (rMTT), and time-to-peak (rTTP) were calculated. Based on postoperative DSA, 48 hemispheres were apportioned to two groups based on rich (grades 2, 3) or poor (grades 0, 1) collateral vessel formation, and the pre- and post-operative differences in perfusion changes were compared. The association between clinical outcome, CTP, and the degree of DSA collateral vessels was explored.
RESULTS: rCBF and rMTT significantly improved in both the poor and rich collateral vessel formation groups (n = 21 and 27, respectively), while rTTP significantly improved only in the latter. Postoperative CTP improved in the rich and the grade 1 collateral vessel groups (p < 0.01). The clinical improvement was consistent with the improvement of CTP (p = 0.07), but less consistent with the degree of collateral angiogenesis (p = 0.003).
CONCLUSION: CTP can quantitatively evaluate the improvement of brain tissue perfusion in the operated area after EDAS. Brain tissue perfusion in operated areas improved regardless of postoperative rich or poor collateral vessel formation observed via DSA. A significant improvement in rTTP in the operated area may indicate the formation of abundant collateral vessels. KEY POINTS: • CTP showed that brain tissue perfusion in the operated area after EDAS improved regardless of rich or poor collateral vessel formation observed via DSA. • Significant improvement of rTTP in the operated area may indicate the formation of abundant collateral vessels.

Entities:  

Keywords:  Angiography; Cerebral revascularization; Moyamoya syndrome; Perfusion imaging

Year:  2021        PMID: 33956177     DOI: 10.1007/s00330-021-07960-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  34 in total

1.  Moyamoya Disease in Children: Results From the International Pediatric Stroke Study.

Authors:  Sarah Lee; Michael J Rivkin; Adam Kirton; Gabrielle deVeber; Jorina Elbers
Journal:  J Child Neurol       Date:  2017-07-17       Impact factor: 1.987

2.  Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults.

Authors:  Jin Pyeong Jeon; Jeong Eun Kim; Won-Sang Cho; Jae Seung Bang; Young-Je Son; Chang Wan Oh
Journal:  J Neurosurg       Date:  2017-05-05       Impact factor: 5.115

3.  Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations.

Authors:  Nestor R Gonzalez; Joshua R Dusick; Mark Connolly; Firas Bounni; Neil A Martin; Barbara Van de Wiele; David S Liebeskind; Jeffrey L Saver
Journal:  J Neurosurg       Date:  2015-06-12       Impact factor: 5.115

4.  Clinical features and outcome in North American adults with moyamoya phenomenon.

Authors:  Christopher L Hallemeier; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Gregory J Zipfel; Ralph G Dacey; Colin P Derdeyn
Journal:  Stroke       Date:  2006-04-27       Impact factor: 7.914

Review 5.  Surgical Management of Moyamoya Disease.

Authors:  Güliz Acker; Lucius Fekonja; Peter Vajkoczy
Journal:  Stroke       Date:  2018-01-17       Impact factor: 7.914

6.  Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.

Authors:  Dong-Kyu Jang; Kwan-Sung Lee; Hyoung Kyun Rha; Pil-Woo Huh; Ji-Ho Yang; Ik Seong Park; Jae-Geun Ahn; Jae Hoon Sung; Young-Min Han
Journal:  J Neurosurg       Date:  2016-11-11       Impact factor: 5.115

Review 7.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

8.  Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan.

Authors:  Satoshi Yamada; Koichi Oki; Yoshiaki Itoh; Satoshi Kuroda; Kiyohiro Houkin; Teiji Tominaga; Susumu Miyamoto; Nobuo Hashimoto; Norihiro Suzuki
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-11-30       Impact factor: 2.136

9.  Surgical outcomes following encephaloduroarteriosynangiosis in adult moyamoya disease associated with Type 2 diabetes.

Authors:  Bin Ren; Zheng-Shan Zhang; Wei-Wei Liu; Xiang-Yang Bao; De-Sheng Li; Cong Han; Peng Xian; Feng Zhao; Hui Wang; Hai Wang; Lian Duan
Journal:  J Neurosurg       Date:  2016-01-08       Impact factor: 5.115

Review 10.  Moyamoya Disease: Treatment and Outcomes.

Authors:  Tackeun Kim; Chang Wan Oh; Jae Seung Bang; Jeong Eun Kim; Won-Sang Cho
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

View more
  2 in total

1.  Radiomics models for preoperative prediction of microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Xian Zhong; Haiyi Long; Liya Su; Ruiying Zheng; Wei Wang; Yu Duan; Hangtong Hu; Manxia Lin; Xiaoyan Xie
Journal:  Abdom Radiol (NY)       Date:  2022-04-01

2.  CT perfusion-based delta-radiomics models to identify collateral vessel formation after revascularization in patients with moyamoya disease.

Authors:  Jizhen Li; Yan Zhang; Di Yin; Hui Shang; Kejian Li; Tianyu Jiao; Caiyun Fang; Yi Cui; Ming Liu; Jun Pan; Qingshi Zeng
Journal:  Front Neurosci       Date:  2022-08-11       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.